10.6084/M9.FIGSHARE.21261604.V1
Wei Zhang
Wei
Zhang
Jinan University
Yan Yang
Yan
Yang
Jinan University
First Affiliated Hospital of Jinan University
Liewen Lin
Liewen
Lin
Jinan University
Jingquan He
Jingquan
He
Jinan University
Jingjing Dong
Jingjing
Dong
Jinan University
First Affiliated Hospital of Jinan University
Bin Yan
Bin
Yan
Jinan University
Wanxia Cai
Wanxia
Cai
Jinan University
Yumei Chen
Yumei
Chen
Jinan University
Lianghong Yin
Lianghong
Yin
Jinan University
First Affiliated Hospital of Jinan University
Donge Tang
Donge
Tang
Jinan University
Fanna Liu
Fanna
Liu
Jinan University
First Affiliated Hospital of Jinan University
Yong Dai
Yong
Dai
0000-0002-6840-9158
Jinan University
Additional file 2 of Comprehensive characterization of ubiquitinome of human colorectal cancer and identification of potential survival-related ubiquitination
Additional file 2. Table S1. Ubiquitination annotation. Table S2. Protein annotation. Table S3. 42 proteins having ten or more than ten ubiquitination modifications. Table S4. 20 ubiquitin-binding motifs. Table S5. 2242 proteins with an upregulated ubiquitination and 1204 proteins with a down-regulated ubiquitination. Table S6. 1172 up-regulated proteins and 1700 down-regulated proteins. Table S7. 646 Secretory proteins. Table S8. 53 proteins having an upregulated expression simultaneously with a down-regulated ubiquitination and 116 proteins having down-regulated expression simultaneously with an up-regulated ubiquitination. Table S9. 7 proteins having an up-regulated expression simultaneously with a down-regulated ubiquitination. Table S10. 52 proteins having a down-regulated expression simultaneously with an up-regulated ubiquitination. Table S11. 101 proteins which were probably associated with the overall survival rates of CRC patients.
Biochemistry
Medicine
Cell Biology
Genetics
Immunology
Biological Sciences not elsewhere classified
Cancer
Hematology
figshare
2022
2022-10-03
2024-02-15
Dataset
9572216 Bytes
10.6084/m9.figshare.21261604
10.1111/jcpt.12850
10.3322/caac.21660
10.3390/jcm10153219
10.1016/j.biocel.2019.105637
10.3389/fonc.2021.601722
10.1016/j.ejphar.2020.173819
10.1038/s41392-020-0196-9
10.1093/brain/aws045
10.1002/ijc.29215
10.1002/humu.24057
10.1002/path.4520
10.1016/j.redox.2020.101702
10.1016/j.cell.2015.03.053
10.1074/mcp.TIR118.000900
10.1007/s40265-017-0701-9
10.1111/jnc.13194
10.3389/fimmu.2017.00399
10.21775/cimb.035.099
10.1016/j.tcb.2015.08.010
10.1186/s12943-020-01262-x
10.3390/cancers13112550
10.7150/thno.54961
10.1007/s00018-021-03816-8
10.3389/fonc.2020.01684
10.3390/diseases9010021
10.3390/cancers13184506
10.3390/cancers13143395
10.1016/j.canlet.2021.07.023
10.3390/cancers13081943
10.1016/j.clinbiochem.2021.06.007
10.1038/s41467-018-07185-y
10.1021/acs.jproteome.7b00156
10.1016/j.mcpro.2021.100050
10.1007/s00401-019-02067-z
10.1186/s12967-022-03645-8
CC BY + CC0